B Winblad
Overview
Explore the profile of B Winblad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
657
Citations
16619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jessen F, Kramberger M, Angioni D, Aarsland D, Balasa M, Bennys K, et al.
J Prev Alzheimers Dis
. 2024 Oct;
11(5):1212-1218.
PMID: 39350366
β-amyloid-targeting antibodies represent the first generation of effective causal treatment of Alzheimer's disease (AD) and can be considered historical research milestones. Their effect sizes, side effects, implementation challenges and costs,...
2.
Aye S, Handels R, Winblad B, Jonsson L
J Prev Alzheimers Dis
. 2024 Jul;
11(4):928-942.
PMID: 39044504
Background: Recent developments in blood biomarkers (BBM) have shown promising results in diagnosing amyloid pathology in Alzheimer's Disease (AD). However, information on how these BBMs can best be used in...
3.
Zhou R, Wimo A, Winblad B
J Prev Alzheimers Dis
. 2024 Jul;
11(4):895-896.
PMID: 39044499
No abstract available.
4.
Mattke S, Gustavsson A, Jacobs L, Kern S, Palmqvist S, Eriksdotter M, et al.
J Prev Alzheimers Dis
. 2024 Jan;
11(1):155-161.
PMID: 38230728
Background: The emergence of disease-modifying Alzheimer's (AD) treatments provides new hope to patients and families but concerns have been raised about the preparedness of healthcare systems to provide timely access...
5.
Kalar I, Xu H, Secnik J, Schwertner E, Kramberger M, Winblad B, et al.
J Intern Med
. 2020 Aug;
289(4):508-522.
PMID: 32854138
Background: The effect of calcium channel blockers (CCB) on mortality and ischaemic stroke risk in dementia patients is understudied. Objectives: To calculate the risk of death and ischaemic stroke in...
6.
Frederiksen K, Cooper C, Frisoni G, Frolich L, Georges J, Kramberger M, et al.
Eur J Neurol
. 2020 Jul;
27(10):1805-1820.
PMID: 32713125
Background And Purpose: Dementia is one of the most common disorders and is associated with increased morbidity, mortality and decreased quality of life. The present guideline addresses important medical management...
7.
Loera-Valencia R, Cedazo-Minguez A, Kenigsberg P, Page G, Duarte A, Giusti P, et al.
J Intern Med
. 2019 Jul;
286(4):398-437.
PMID: 31286586
Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its progression. The most...
8.
Winblad B, Ankarcrona M, Johansson G, Novak P, Peter Thelin E, Zetterberg H, et al.
J Intern Med
. 2019 May;
285(6):591-593.
PMID: 31090251
No abstract available.
9.
Zetterberg H, Winblad B, Bernick C, Yaffe K, Majdan M, Johansson G, et al.
J Intern Med
. 2018 Nov;
285(6):624-634.
PMID: 30481401
Traumatic brain injury (TBI) is clinically divided into a spectrum of severities, with mild TBI being the least severe form and a frequent occurrence in contact sports, such as ice...
10.
Petek B, Villa-Lopez M, Loera-Valencia R, Gerenu G, Winblad B, Kramberger M, et al.
J Intern Med
. 2018 Sep;
284(6):620-642.
PMID: 30264910
Millions of people worldwide receive agents targeting the renin-angiotensin system (RAS) to treat hypertension or statins to lower cholesterol. The RAS and cholesterol metabolic pathways in the brain are autonomous...